Tolvaptan administration

2 trials

Sponsors

Kyorin University School of Medicine, Tokyo Women's Medical University

Conditions

Autosomal Dominant Polycystic Kidney Diseasecongenital heart disease

Phase 4

Clinical Efficacy Study of Tolvaptan on Patients with Autosomal Dominant Polycystic Kidney Disease

Active, not recruitingJPRN-UMIN000015715

Kyorin University School of MedicineAutosomal Dominant Polycystic Kidney Disease

Start: 2014-11-20Target: 100Updated: 2026-06-29

Unknown Phase

Diuretic effect of tolvaptan in congenital heart disease Multi-center study

RecruitingJPRN-UMIN000018004

Tokyo Women's Medical Universitycongenital heart disease

Start: 2014-04-12Target: 20Updated: 2026-06-29